SMLR - הכנסה תפעולית לפני ניכוי פחת semlerscientific.com

Risks for Semler Scientific, Inc. (SMLR) depend on the recruitment of qualified engineers and medical representatives to promote medtech. The actual operating profit confirms the business's resilience, where the value of 0.00 serves as the current metric. Software patents ensure stability by creating a monopoly within clinics, while regular purchases of consumables for FloChec systems provide high margins and financial strength.

This metric measures the net daily cash flow from core operations before depreciation, allowing for an assessment of the business's real operational efficiency. The current value of 0.00 at the base EBITDA level reflects the ability of Semler Scientific, Inc. (SMLR) to convert its aggressive vascular diagnostics sales strategy into liquidity, while extreme growth in this metric may signal market overheating and an impending correction.